NOVEL TRICYCLIC COMPOUNDS
The invention provides a compound of Formula (Ia), (Ib), (Ic), (Id), (Ie), (If), (Ig), (Ih), (Ii), (Ij), (Ik), or (Il) as defined herein, pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The comp...
Saved in:
Main Authors | , , , , , , , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English Spanish |
Published |
19.06.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The invention provides a compound of Formula (Ia), (Ib), (Ic), (Id), (Ie), (If), (Ig), (Ih), (Ii), (Ij), (Ik), or (Il) as defined herein, pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
La invención proporciona un compuesto de Fórmula (la), (Ib), (Ic), (Id), (le), (If), (lg), (Ih), (Ii), (lj), (1k), o (II) como se define en la presente, sales farmacéuticamente aceptables, profármacos, metabilitos biológicamente activos, estereoisómeros e isómeros de los mismos en donde las variables son como se define en la presente. Los compuestos de la invención son útiles para tratar condiciones inmunológicas y oncológicas. |
---|---|
AbstractList | The invention provides a compound of Formula (Ia), (Ib), (Ic), (Id), (Ie), (If), (Ig), (Ih), (Ii), (Ij), (Ik), or (Il) as defined herein, pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
La invención proporciona un compuesto de Fórmula (la), (Ib), (Ic), (Id), (le), (If), (lg), (Ih), (Ii), (lj), (1k), o (II) como se define en la presente, sales farmacéuticamente aceptables, profármacos, metabilitos biológicamente activos, estereoisómeros e isómeros de los mismos en donde las variables son como se define en la presente. Los compuestos de la invención son útiles para tratar condiciones inmunológicas y oncológicas. |
Author | ERIC C. BREINLINGER KELLY D. MULLEN MARIA A. ARGIRIADI DAWN M. GEORGE GRIER A. WALLACE LU WANG BIQIN C. LI JEFFREY W. VOSS KRISTINE E. FRANK ERIC R. GOEDKEN NATHAN S. JOSEPHSOHN ANNA M. ERICSSON GAGANDEEP SOMAL MICHAEL FRIEDMAN NEIL WISHART BRYAN A. FIAMENGO KENT D. STEWART MICHAEL J. MORYTKO DAVID J. CALDERWOOD KEVIN R. WOLLER |
Author_xml | – fullname: DAWN M. GEORGE – fullname: BRYAN A. FIAMENGO – fullname: NEIL WISHART – fullname: DAVID J. CALDERWOOD – fullname: ERIC C. BREINLINGER – fullname: LU WANG – fullname: MICHAEL FRIEDMAN – fullname: ANNA M. ERICSSON – fullname: KELLY D. MULLEN – fullname: JEFFREY W. VOSS – fullname: ERIC R. GOEDKEN – fullname: GRIER A. WALLACE – fullname: GAGANDEEP SOMAL – fullname: MARIA A. ARGIRIADI – fullname: KENT D. STEWART – fullname: BIQIN C. LI – fullname: KRISTINE E. FRANK – fullname: NATHAN S. JOSEPHSOHN – fullname: MICHAEL J. MORYTKO – fullname: KEVIN R. WOLLER |
BookMark | eNrjYmDJy89L5WSQ9PMPc_VRCAnydI509vF0VnD29w3wD_VzCeZhYE1LzClO5YXS3AxKbq4hzh66qQX58anFBYnJqXmpJfG-EUYGhkYGBmbGFoaOxkQpAgA1fiJY |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences Forestry Agriculture |
DocumentTitleAlternate | NUEVOS COMPUESTOS TRICICLICOS. |
ExternalDocumentID | MX2012006381A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_MX2012006381A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:52:21 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English Spanish |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_MX2012006381A3 |
Notes | Application Number: MX20120006381 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120619&DB=EPODOC&CC=MX&NR=2012006381A |
ParticipantIDs | epo_espacenet_MX2012006381A |
PublicationCentury | 2000 |
PublicationDate | 20120619 |
PublicationDateYYYYMMDD | 2012-06-19 |
PublicationDate_xml | – month: 06 year: 2012 text: 20120619 day: 19 |
PublicationDecade | 2010 |
PublicationYear | 2012 |
RelatedCompanies | ABBOTT LABORATORIES. |
RelatedCompanies_xml | – name: ABBOTT LABORATORIES. |
Score | 2.7241397 |
Snippet | The invention provides a compound of Formula (Ia), (Ib), (Ic), (Id), (Ie), (If), (Ig), (Ih), (Ii), (Ij), (Ik), or (Il) as defined herein, pharmaceutically... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | AGRICULTURE ANIMAL HUSBANDRY BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES FISHING FORESTRY HUMAN NECESSITIES HUNTING HYGIENE MEDICAL OR VETERINARY SCIENCE PEST REPELLANTS OR ATTRACTANTS PLANT GROWTH REGULATORS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTSTHEREOF TRAPPING |
Title | NOVEL TRICYCLIC COMPOUNDS |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120619&DB=EPODOC&locale=&CC=MX&NR=2012006381A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTS3TDIxMUrStUxKBA3dmADLQeNkI90k0zSjlBRTg1Rz8Al8vn5mHqEmXhGmEUwM2bC9MOBzQsvBhyMCc1QyML-XgMvrAsQglgt4bWWxflImUCjf3i3E1kUN2js2NAJWT5ZqLk62rgH-Lv7Oas7Otr4Ran5BEDlQ9WzoyMzACmxHm4Oyg2uYE2hbSgFyneImyMAWADQur0SIgSm1WJiB2zG9CHoORqowA6cz7CI2YQYO0PWZUKYvdCocyITmymIRBkk__zBXH4WQIE_nSGcfT2cFZ3_fAP9QP5dgUQYlN9cQZw9doOXxcK_G-0YgOdRYjIElLz8vVYJBwdAk0dzELMUixTg1zcTS0DjJwDTFJNU4MdXQzCIpJdVckkEaj0FSeGWlGbhAPND6J0NLGQaWkqLSVFlgTVuSJAcOIQCjYX4D |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8JAEJ4gGtGTVo2Ij8aY3oi03VJ6aAxs2xTtg2Ah9US6dDHGpBBa4993txblxG2yk8w-km9md3YeAA-JbhCEFNI2SMJdN4jpQXWutIm2UNJU61C9rMDnB113gp5jLa7B5yYXpqwT-l0WR2SImjO8F6W-Xv07sawytjJ_JB9saPnkRKYlVa9jWWHmyZCsgWmPQivEEsamH0vB-JfHzbPc34N9dsfWORzs6YCnpay2bYpzAgcjJi4rTqFGcwGO--_rqg4GFaCBN43YBDjk7TMr0q--whlZoTI_g2YQTm1PjMZD_Ia9IRZx6I_CSWC9nsO9Y0fYbbPJZ39bnfnx1kLVC6hny4xegiijREfdtJeqdIEMWSUdLUVUTajc7ZGU6k1o7RB0tZN7Bw038r2ZNwxeWnDEOTwWSjauoV6sv-gNs7oFuS1P6we3Y4D2 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=NOVEL+TRICYCLIC+COMPOUNDS&rft.inventor=DAWN+M.+GEORGE&rft.inventor=BRYAN+A.+FIAMENGO&rft.inventor=NEIL+WISHART&rft.inventor=DAVID+J.+CALDERWOOD&rft.inventor=ERIC+C.+BREINLINGER&rft.inventor=LU+WANG&rft.inventor=MICHAEL+FRIEDMAN&rft.inventor=ANNA+M.+ERICSSON&rft.inventor=KELLY+D.+MULLEN&rft.inventor=JEFFREY+W.+VOSS&rft.inventor=ERIC+R.+GOEDKEN&rft.inventor=GRIER+A.+WALLACE&rft.inventor=GAGANDEEP+SOMAL&rft.inventor=MARIA+A.+ARGIRIADI&rft.inventor=KENT+D.+STEWART&rft.inventor=BIQIN+C.+LI&rft.inventor=KRISTINE+E.+FRANK&rft.inventor=NATHAN+S.+JOSEPHSOHN&rft.inventor=MICHAEL+J.+MORYTKO&rft.inventor=KEVIN+R.+WOLLER&rft.date=2012-06-19&rft.externalDBID=A&rft.externalDocID=MX2012006381A |